首页> 外文OA文献 >PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER

【2h】

PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER

机译：PCN48通过启动帕洛诺西酮与其他5-羟丙胺3受体拮抗剂以预防化疗引起的恶心和癌症患者呕吐（CINV）对医院门诊的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Craver C.; Gayle J.; Balu S.; Buchner D.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting. [J] . Balu S, Buchner D, Craver C, Clinical therapeutics . 2011,第4期

机译：帕洛诺司琼与其他5-HT（3）受体拮抗剂在医院门诊接受化疗的癌症患者中预防化疗引起的恶心和呕吐。
2. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States [J] . SchwartzbergL., MorrowG., BaluS., Current medical research and opinion . 2011,第8期

机译：在美国医院门诊患者中，用帕洛诺司琼与其他5-HT3受体拮抗剂进行化学疗法诱导的恶心，呕吐和止吐预防
3. Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy [J] . Bruce Feinberg, James Gilmore, Sally Haislip, Supportive Care in Cancer . 2012,第3期

机译：帕洛诺司琼与昂丹司琼联合开始止吐预防对接受多日化疗的肺癌患者化疗不受控制的恶心和呕吐风险的影响
4. The Effect of Acupressure Wristbands Toward Acute Nausea and Vomiting on Post-Chemotherapy Cervix Cancer Patient in Prof. Dr. Margono Soekarjo Hospital Purwokerto [C] . Efita Yulianasari, Siti Haniyah, Indri Heri Susanti International Conference on Community Health . 2020

机译：Acu压抑腕带对急性恶心的影响，呕吐在化疗后宫颈癌患者Margono Soekarjo医院Purwokerto博士
5. A randomized phase III study evaluating the efficacy of single-dose NEPA a fixed antiemetic combination of netupitant and palonosetron versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC) [O] . L Zhang, S Lu, J Feng, -1

机译：一项III期随机研究评估单剂量NEPAnetupitant和palonosetron的固定止吐药与预防性方案在接受高促发性化疗（HEC）的患者中预防化疗引起的恶心和呕吐（CINV）的疗效
6. PCN1 CHEMOTHERAPY INDUCED NAUSEA AND VOMITING EVENT RATE AMONG PATIENTS WITH CANCER TREATED WITH HIGHLY OR MODERATELY EMETOGENIC CHEMOTHERAPY AND INITIATED ON PALONOSETRON VERSUS OTHER 5-HT3-RECEPTOR ANTAGONIST ANTI-EMETIC PROPHYLAXIS IN A HOSPITAL OUTPATIENT SETTING [O] . Craver C., Gayle J., Balu S., 2011

机译：PCN1化疗可诱发恶性肿瘤，并在接受高度或中度致癌化学治疗的癌症患者中呕吐事件发生率，并通过古洛酮组与其他5-HT3-受体拮抗剂在医院进行的拮抗剂治疗相关。

PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER

著录项

引文网络

相似文献

相关主题

期刊订阅